天域生物(603717) - 2025 Q4 - 年度业绩预告

Financial Performance Expectations - The company expects a net profit attributable to shareholders of the parent company for 2025 to be between -125 million and -85 million RMB[6]. - The expected net profit attributable to shareholders of the parent company, after deducting non-recurring gains and losses, is projected to be between -165 million and -120 million RMB[6]. - In the previous year, the net profit attributable to shareholders was -107.36 million RMB, with a total profit of -87.16 million RMB[9]. - The performance forecast is based on preliminary calculations and has not been audited by registered accountants, highlighting potential investment risks[16]. - The company emphasizes that the financial data provided is preliminary and will be finalized in the audited annual report[17]. Sales and Revenue Trends - The company experienced a 22.92% year-on-year increase in pig sales volume, but revenue from pig farming declined due to falling prices[11]. - The average selling price of pigs showed a "high first, low later" trend, significantly decreasing in the second half of the year[11]. Business Operations and Impairments - The company is continuing to shrink its ecological environment business, with some project settlements not meeting expectations, leading to ongoing losses[11]. - The company has made impairment provisions for biological assets and accounts receivable in accordance with accounting standards, contributing to the overall losses[11]. One-time Gains - The company anticipates a one-time gain of approximately 24.10 million RMB from the disposal of a right-of-use asset due to a significant reduction in annual rent[12].